Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma HCCReport as inadecuate




Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma HCC - Download this document for free, or read online. Document in PDF available to download.

Journal for ImmunoTherapy of Cancer

, 2:P98

First Online: 06 November 2014DOI: 10.1186-2051-1426-2-S3-P98

Cite this article as: Duffy, A., Kerkar, S.P., Kleiner, D.E. et al. j. immunotherapy cancer 2014 2Suppl 3: P98. doi:10.1186-2051-1426-2-S3-P98 Download fulltext PDF



Author: Austin Duffy - Sid P Kerkar - David E Kleiner - Susanna Ulahannan - Metin Kurtoglu - Oxana Rusher - Suzanne Fioravanti -

Source: https://link.springer.com/







Related documents